These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29667779)

  • 1. MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway.
    Pan Y; Hu J; Ma J; Qi X; Zhou H; Miao X; Zheng W; Jia L
    Mol Carcinog; 2018 Aug; 57(8):1067-1077. PubMed ID: 29667779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal microRNA-15a from ACHN cells aggravates clear cell renal cell carcinoma via the BTG2/PI3K/AKT axis.
    Li DY; Lin FF; Li GP; Zeng FC
    Kaohsiung J Med Sci; 2021 Nov; 37(11):973-982. PubMed ID: 34337864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-193a/b-3p during HPV-induced cervical carcinogenesis contributes to anchorage-independent growth through PI3K-AKT pathway regulators.
    Xu M; Huseinovic A; Jaspers A; Yuan L; Steenbergen RDM
    J Med Virol; 2023 Mar; 95(3):e28589. PubMed ID: 36799263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.
    Liu L; Li Y; Liu S; Duan Q; Chen L; Wu T; Qian H; Yang S; Xin D
    Tumour Biol; 2017 Jun; 39(6):1010428317711951. PubMed ID: 28639901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-613 suppresses renal cell carcinoma proliferation, invasion and migration by regulating the AXL/AKT pathway.
    Duan W; Pan S; Zhai Y; Deng Q; Ren W; Du C; Sun Y
    Exp Biol Med (Maywood); 2023 Feb; 248(4):281-292. PubMed ID: 36852468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased miR-200a-3p is a key regulator of renal carcinoma growth and migration by directly targeting CBL.
    Ding M; Sun X; Zhong J; Zhang C; Tian Y; Ge J; Zhang CY; Zen K; Wang JJ; Zhang C; Wang C
    J Cell Biochem; 2018 Dec; 119(12):9974-9985. PubMed ID: 30171729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-203 inhibits epithelial-mesenchymal transition, migration, and invasion of renal cell carcinoma cells via the inactivation of the PI3K/AKT signaling pathway by inhibiting CAV1.
    Han N; Li H; Wang H
    Cell Adh Migr; 2020 Dec; 14(1):227-241. PubMed ID: 32990143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-derived exosomal miR-342-3p promotes the progression of renal cell carcinoma through the NEDD4L/CEP55 axis.
    Feng J; Xu B; Dai C; Wang Y; Xie G; Yang W; Zhang B; Li X; Wang J
    Oncol Res; 2021; 29(5):331-349. PubMed ID: 37305161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma.
    Lyu J; Zhu Y; Zhang Q
    Cancer Biomark; 2020; 28(2):141-149. PubMed ID: 32116235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-302c-3p inhibits renal cell carcinoma cell proliferation by targeting Grb2-associated binding 2 (Gab2).
    Gu DH; Mao JH; Pan XD; Zhu H; Chen X; Zheng B; Shan Y
    Oncotarget; 2017 Apr; 8(16):26334-26343. PubMed ID: 28412750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FGD5-AS1/miR-5590-3p axis facilitates the proliferation and metastasis of renal cell carcinoma through ERK/AKT signalling.
    Yang Y; Dong MH; Hu HM; Min QH; Xiao L
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8756-8766. PubMed ID: 32964964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.
    Dong Y; Gao Y; Xie T; Liu H; Zhan X; Xu Y
    Biomed Res Int; 2021; 2021():9950749. PubMed ID: 34307682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-148a suppresses human renal cell carcinoma malignancy by targeting AKT2.
    Cao H; Liu Z; Wang R; Zhang X; Yi W; Nie G; Yu Y; Wang G; Zhu M
    Oncol Rep; 2017 Jan; 37(1):147-154. PubMed ID: 27878305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of growth 4 inhibits cell proliferation, migration, and induces apoptosis of renal cell carcinoma cells.
    Sun J; Xie L; Lv J; Zhang W; Lv J; Liang Y; Geng Y; Li X
    J Cell Biochem; 2019 Apr; 120(4):6709-6717. PubMed ID: 30390334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway.
    Li Z; Ma Z; Xu X
    Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.